Millipore debuts antibody learning center

20 April 2008

Massachusetts, USA-based Millipore Corp, a life science firm providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, has launched a new Antibody Learning Center, a free web tool for navigating the company's broad antibody portfolio and planning efficient workflows for immunodetection in specific focus areas of protein research.

Now that Upstate and Chemicon are part of Millipore, the group's antibody offerings span the entire range of biological research, from neuroscience, cell signaling and nuclear function, to cell structure and adhesion, and apoptosis. The Antibody Learning Center conveniently organizes the entire antibody collection into specific focus areas. Researchers can quickly find the relevant antibodies to answer a particular question while they are also alerted to important, related proteins, extending the scope of their research, says Millipore. For more information, visit: www.millipore.com/antibodies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight